Celgene Global Health , a division of Celgene Corporation , and the Drugs for Neglected Diseases initiative strengthen their collaboration with a four-year Research Collaboration Agreement to identify and optimize new drug candidates for the treatment of neglected tropical diseases . Celgene will provide DNDi with new data and resources to accelerate clinical development of new treatments for patients with NTDs.